{"id":49919,"date":"2026-09-30T12:50:04","date_gmt":"2026-09-30T11:50:04","guid":{"rendered":"https:\/\/bnssghealthiertogether.org.uk\/?post_type=library&p=49919"},"modified":"2026-09-30T12:50:04","modified_gmt":"2026-09-30T11:50:04","slug":"foi-icb-2627-244-nice-ta1152-semaglutide-for-cvd-risk-reduction","status":"publish","type":"library","link":"https:\/\/bnssghealthiertogether.org.uk\/ro\/library\/foi-icb-2627-244-nice-ta1152-semaglutide-for-cvd-risk-reduction\/","title":{"rendered":"FOI.ICB-2627\/244: NICE TA1152 (Semaglutide for CVD Risk Reduction)"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":0,"parent":0,"template":"","categories":[299],"class_list":["post-49919","library","type-library","status-publish","hentry","category-freedom-of-information"],"acf":[],"_links":{"self":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/ro\/wp-json\/wp\/v2\/library\/49919","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/ro\/wp-json\/wp\/v2\/library"}],"about":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/ro\/wp-json\/wp\/v2\/types\/library"}],"version-history":[{"count":2,"href":"https:\/\/bnssghealthiertogether.org.uk\/ro\/wp-json\/wp\/v2\/library\/49919\/revisions"}],"predecessor-version":[{"id":49922,"href":"https:\/\/bnssghealthiertogether.org.uk\/ro\/wp-json\/wp\/v2\/library\/49919\/revisions\/49922"}],"wp:attachment":[{"href":"https:\/\/bnssghealthiertogether.org.uk\/ro\/wp-json\/wp\/v2\/media?parent=49919"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bnssghealthiertogether.org.uk\/ro\/wp-json\/wp\/v2\/categories?post=49919"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}